BLUSENSE DIAGNOSTICS APS
Credit rating
Company information
About BLUSENSE DIAGNOSTICS APS
BLUSENSE DIAGNOSTICS APS (CVR number: 36059184) is a company from KØBENHAVN. The company recorded a gross profit of -12489 kDKK in 2021. The operating profit was -31.9 mDKK, while net earnings were -26.5 mDKK. The profitability of the company measured by Return on Assets (ROA) was -108.5 %, which can be considered poor and Return on Equity (ROE) was -163.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 71.1 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. BLUSENSE DIAGNOSTICS APS's liquidity measured by quick ratio was 3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -8 750.00 | -9 396.00 | -12 218.00 | -8 577.00 | -12 489.00 |
EBIT | -17 885.00 | -22 587.00 | -33 284.00 | -28 780.00 | -31 904.00 |
Net earnings | -14 496.00 | -18 778.00 | -27 957.00 | -23 380.00 | -26 528.00 |
Shareholders equity total | 12 691.00 | 7 893.00 | -8 551.00 | 5 319.00 | 27 219.00 |
Balance sheet total (assets) | 16 357.00 | 13 989.00 | 38 967.00 | 20 561.00 | 38 264.00 |
Net debt | -8 617.00 | -6 609.00 | 8 774.00 | 412.00 | -18 868.00 |
Profitability | |||||
EBIT-% | |||||
ROA | -136.7 % | -148.4 % | -108.2 % | -84.5 % | -108.5 % |
ROE | -147.7 % | -182.5 % | -119.3 % | -105.6 % | -163.1 % |
ROI | -180.7 % | -218.1 % | -143.7 % | -106.9 % | -134.8 % |
Economic value added (EVA) | -13 718.73 | -16 800.50 | -25 153.26 | -19 581.15 | -21 504.06 |
Solvency | |||||
Equity ratio | 77.6 % | 56.4 % | -18.0 % | 25.9 % | 71.1 % |
Gearing | 0.8 % | -448.7 % | 190.9 % | 17.1 % | |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 3.6 | 1.8 | 2.0 | 2.8 | 3.0 |
Current ratio | 3.6 | 1.8 | 2.0 | 2.8 | 3.1 |
Cash and cash equivalents | 8 617.00 | 6 670.00 | 29 597.00 | 9 743.00 | 23 510.00 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | B | B | B | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.